Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking

Molecular Biology Reports

Volumn 39, Issue 8, 2012, Pages 8335-8344

  Han, Fujun ^a,b   Wang, Xinsheng ^c   Wang, Xuhui ^d   Luo, Yongfeng ^e   Li, Wei ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c People's Liberation Army No 458 Hospital   (China)

^d Ji Lin Tumour Hospital   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

2A; 2C; A4889G; CYP1A1; Gastric cancer; Meta analysis; Polymorphism; rs1048943; rs4646903; Smoking; T6235C

Indexed keywords

ADENOSINE; CYTOCHROME P450 1A1; CYTOSINE; GUANINE; THYMINE;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; CYP1A1 GENE; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING; STOMACH CANCER; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

NICOTIANA TABACUM;

ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

EID: 84868637596     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1683-z     Document Type: Article

References (56)

1. Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, Ito S, Sawaki A, Iida S, Sato S, Yatabe Y, Yamao K, Ueda R, Tajima K, Hamajima N, Tanaka H (2011) ABO genotype and the risk of gastric cancer, atrophic gastritis, and helicobacter pylori infection. Cancer Epidemiol Biomark Prev 20(8):1665-1672. doi: 10.1158/1055-9965.EPI-11-0213
2. Duell EJ, Travier N, Lujan-Barroso L, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Quiros JR, Sanchez-Cantalejo E, Navarro C, Gurrea AB, Dorronsoro M, Khaw KT, Allen NE, Key TJ, Bueno-de-Mesquita HB, Ros MM, Numans ME, Peeters PH, Trichopoulou A, Naska A, Dilis V, Teucher B, Kaaks R, Boeing H, Schutze M, Regner S, Lindkvist B, Johansson I, Hallmans G, Overvad K, Egeberg R, Tjonneland A, Lund E, Weiderpass E, Braaten T, Romieu I, Ferrari P, Jenab M, Stenling R, Aune D, Norat T, Riboli E, Gonzalez CA (2011) Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr 94(5):1266-1275. doi: 10.3945/ajcn.111.012351
3. Parkin DM (2004) International variation. Oncogene 23(38):6329-6340. doi: 10.1038/sj.onc.1207726
4. Ebert MP, Niemeyer D, Deininger SO, Wex T, Knippig C, Hoffmann J, Sauer J, Albrecht W, Malfertheiner P, Rocken C (2006) Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry. J Proteome Res 5(9):2152-2158. doi: 10.1021/pr060011c
5. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomark Prev 9(1):3-28
6. Bartsch H, Dally H, Popanda O, Risch A, Schmezer P (2007) Genetic risk profiles for cancer susceptibility and therapy response. Recent Results Cancer Res 174:19-36
7. Ingelman-Sundberg M (2001) Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mutat Res 482(1-2):11-19
8. Hayashi S, Watanabe J, Nakachi K, Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110(3):407-411
9. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263(1):131-133
10. Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Li HL, Tian XP, Dong JH, Zhang L, Xu J, Shi W, Ma TY (2011) CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies. Eur J Cancer Prev 20(6):445-452. doi: 10.1097/CEJ.0b013e328345f937
11. Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK (2011) CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res 30:99. doi: 10.1186/1756-9966-30-99
12. Chen Z, Li Z, Niu X, Ye X, Yu Y, Lu S (2011) The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis 26(3):437-446. doi: 10.1093/mutage/ger002
13. Jin JQ, Hu YY, Niu YM, Yang GL, Wu YY, Leng WD, Xia LY (2011) CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol 17(2):260-266. doi: 10.3748/wjg.v17.i2.260
14. Zheng Y, Wang JJ, Sun L, Li HL (2011) Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep. doi: 10.1007/s11033-011-1126-2
15. Yao L, Yu X, Yu L (2010) Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects. Breast Cancer Res Treat 122(2):503-507. doi: 10.1007/s10549-009-0717-2
16. Sergentanis TN, Economopoulos KP (2010) Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122(2):459-469. doi: 10.1007/s10549-009-0694-5
17. Terrin N, Schmid CH, Lau J (2005) In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 58(9):894-901. doi: S0895-4356(05)00082-X
18. Nan HM, Song YJ, Yun HY, Park JS, Kim H (2005) Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 11(25):3834-3841
19. Nan HM, Park JW, Song YJ, Yun HY, Park JS, Hyun T, Youn SJ, Kim YD, Kang JW, Kim H (2005) Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol 11(21):3175-3181
20. Agundez JA (2004) Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5(3):211-224
21. Hengstler JG, Arand M, Herrero ME, Oesch F (1998) Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154:47-85
22. Roth MJ, Abnet CC, Johnson LL, Mark SD, Dong ZW, Taylor PR, Dawsey SM, Qiao YL (2004) Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control 15(10):1077-1083
23. Darazy M, Balbaa M, Mugharbil A, Saeed H, Sidani H, Abdel-Razzak Z (2011) CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese. Genet Test Mol Biomark 15(6):423-429. doi: 10.1089/gtmb.2010.0206
24. Lee K, Caceres D, Varela N, Csendes DA, Rios RH, Quinones SL (2006) Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers. Rev Med Chil 134(9):1107-1115. doi: /S0034-98872006000900004
25. Luo YP, Chen HC, Khan MA, Chen FZ, Wan XX, Tan B, Ou-Yang FD, Zhang DZ (2011) Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility. Tumour Biol 32(1):215-222. doi: 10.1007/s13277-010-0115-8
26. Gonzalez A, Ramirez V, Cuenca P, Sierra R (2004) Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility. Rev Biol Trop 52(3):591-600
27. Agudo A, Sala N, Pera G, Capella G, Berenguer A, Garcia N, Palli D, Boeing H, Del Giudice G, Saieva C, Carneiro F, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Siman H, Stenling R, Hallmans G, Martinez C, Bilbao R, Barricarte A, Navarro C, Quiros JR, Allen N, Key T, Bingham S, Khaw KT, Linseisen J, Nagel G, Overvad K, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Boshuizen HC, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Lund E, Offerhaus J, Jenab M, Ferrari P, Norat T, Riboli E, Gonzalez CA (2006) Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 15(12):2427-2434. doi: 10.1158/1055-9965.EPI-06-0072
28. Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D'Ugo D, La Torre G, van Duijn CM, Ricciardi G (2007) Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 7:206. doi: 10.1186/1471-2407-7-206
29. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B (2009) Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer 40(1-2):26-32. doi: 10.1007/s12029-009-9072-0
30. Ma JX, Zhang KL, Liu X, Ma YL, Pei LN, Zhu YF, Zhou L, Chen XY, Kong QY, Li H, Liu J (2006) Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China. Cancer Lett 240(2):253-260. doi: 10.1016/j.canlet.2005.09.020
31. Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Sakamoto H, Yoshida T, Tsugane S (2009) Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case-control study in Japan. Gastric Cancer 12(4):198-205. doi: 10.1007/s10120-009-0523-x
32. Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH (2007) GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev 31(3):233-236. doi: 10.1016/j.cdp.2007.03. 004
33. Shen J, Wang RT, Xu YC, Wang LW, Wang XR (2005) Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol 11(38):6056-6060
34. Suzuki S, Muroishi Y, Nakanishi I, Oda Y (2004) Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 39(3):220-230. doi: 10.1007/s00535-003-1281-x
35. Li H, Chen XL, Li HQ (2005) Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol 11(37):5757-5762
36. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A (1997) Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 72(4):565-573
37. Huang RY, Chen GG (2011) Cigarette smoking, cyclooxygenase-2 pathway and cancer. Biochim Biophys Acta 1815(2):158-169. doi: 10.1016/j.bbcan.2010.11.005
38. Finkelstein MM, Verma DK (2004) A cohort study of mortality among Ontario pipe trades workers. Occup Environ Med 61(9):736-742. doi: 10.1136/oem.2003. 011916
39. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N (2008) Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 19(7):689-701
40. La Torre G, Chiaradia G, Gianfagna F, De Lauretis A, Boccia S, Mannocci A, Ricciardi W (2009) Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori 95(1):13-22
41. Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3(10):733-744
42. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso NE (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4(5):242-246
43. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, Nebert DW (1991) Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48(4):720-725
44. Cosma G, Crofts F, Taioli E, Toniolo P, Garte S (1993) Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 40(2-3):309-316
45. Kiyohara C, Hirohata T, Inutsuka S (1996) The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Japanese J Cancer Res Gann 87(1):18-24
46. Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminsky LS (1996) Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res 56(17):3926-3933
47. Persson I, Johansson I, Ingelman-Sundberg M (1997) In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun 231(1):227-230
48. Bufalo NE, Leite JL, T Guilhen AC, Morari EC, Granja F, Assumpcao LVM, Ward LS (2006) Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocr Relat Cancer 13(4):1185-1193. doi: 10.1677/Erc-06-0002
49. Ozlu T, Bulbul Y (2005) Smoking and lung cancer. Tuberk Toraks 53(2):200-209
50. Attia J, Thakkinstian A, McElduff P, Milne E, Dawson S, Scott RJ, Klerk Nd, Armstrong B, Thompson J (2010) Detecting genotyping error using measures of degree of Hardy-Weinberg disequilibrium. Stat Appl Genet Mol Biol 9 (1):Article 5
51. Li B, Leal SM (2009) Deviations from Hardy-Weinberg equilibrium in parental and unaffected sibling genotype data. Hum Hered 67(2):104-115
52. Stadtlander CT, Waterbor JW (1999) Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20(12):2195-2208
53. Florou D, Papadopoulos IN, Scorilas A (2010) Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun 391(1):214-218. doi: 10.1016/j.bbrc.2009.11.034
54. Liu JL, Liang Y, Wang ZN, Zhou X, Xing LL (2010) Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis. World J Gastroenterol 16(43):5510-5517
55. Gonzalez CA, Lopez-Carrillo L (2010) Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 45(1):6-14. doi: 10.3109/00365520903401959
56. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634